Oscar Health, Inc.
OSCR
$23.62
-$0.11-0.46%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 52.58% | 17.12% | 23.10% | 29.06% | 42.37% |
| Total Other Revenue | 32.06% | 86.31% | 79.65% | 24.20% | -23.15% |
| Total Revenue | 52.55% | 17.25% | 23.21% | 29.04% | 42.20% |
| Cost of Revenue | 42.94% | 26.87% | 29.06% | 49.41% | 45.34% |
| Gross Profit | 80.18% | -43.43% | -4.73% | -39.10% | 33.88% |
| SG&A Expenses | 46.29% | 9.71% | 13.30% | 22.81% | 22.48% |
| Depreciation & Amortization | 4.28% | -14.65% | -2.51% | -8.30% | -13.84% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 43.43% | 23.57% | 26.03% | 43.82% | 40.50% |
| Operating Income | 136.97% | -125.92% | -167.19% | -439.89% | 60.12% |
| Income Before Tax | 142.45% | -129.48% | -166.27% | -483.17% | 61.48% |
| Income Tax Expenses | 55.45% | 38.86% | -187.04% | -208.80% | 1,175.60% |
| Earnings from Continuing Operations | 146.46% | -129.92% | -152.78% | -505.76% | 55.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 88.51% | 32.44% | 116.35% | 223.81% | -106.14% |
| Net Income | 146.66% | -129.64% | -151.76% | -506.29% | 55.20% |
| EBIT | 136.97% | -125.92% | -167.19% | -439.89% | 60.12% |
| EBITDA | 134.03% | -135.29% | -198.33% | -396.39% | 57.14% |
| EPS Basic | 107.86% | -101.24% | -136.02% | -479.49% | 42.94% |
| Normalized Basic EPS | 104.58% | -100.72% | -148.04% | -458.48% | 48.68% |
| EPS Diluted | 125.61% | -82.65% | -136.02% | -537.87% | 47.21% |
| Normalized Diluted EPS | 125.24% | -100.72% | -148.04% | -556.56% | 55.02% |
| Average Basic Shares Outstanding | 18.67% | 14.12% | 6.65% | 7.06% | 8.57% |
| Average Diluted Shares Outstanding | 7.78% | 14.12% | 6.65% | -15.93% | 4.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |